8 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney TransplantAntibody-Mediated Rejection (AMR)Not yet recruitingPhase 22026-10-01NCT07613359
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 RiskHemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, myeloproliferative neoplasm, primary myelofibrosisActive, not recruitingPhase 32026-08-13NCT06468033
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia GravisNeoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndromeActive, not recruitingPhase 32026-07-08NCT05070858
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitisRecruitingPhase 22026-05-22NCT06764615
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With NarcolepsyDisorders of Excessive Somnolence, Dyssomnias, Sleep Disorders, Intrinsic, narcolepsy, nervous system disorder, psychiatric disorder, sleep-wake disorderRecruitingPhase 22026-05-14NCT07493265
Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part SarcomaNeoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, alveolar soft part sarcoma, myomatous neoplasm, neoplasm, sarcomaRecruitingPhase 22026-04-23NCT07548177
A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant TumorsAdvanced Malignant TumorsRecruitingPhase 12026-01-21NCT07043751
NAC for Treatment-Resistant OCD and Other Related Disordersanxiety disorder, obsessive-compulsive disorder, psychiatric disorderActive, not recruitingPhase 42025-09-03NCT06956157